CEL SCI CORP (CVM) Chief Scientific Officer receives 2,307-share stock grant

Rhea-AI Filing Summary

TALOR EYAL reported acquisition or exercise transactions in this Form 4 filing.

CEL SCI CORP Chief Scientific Officer receives stock grant. Chief Scientific Officer Talor Eyal was granted 2,307 shares of CEL SCI CORP common stock at a reference price of $1.04 per share. After this compensation-related award, Eyal directly holds a total of 9,318 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider TALOR EYAL

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,307	$1.04	$2K

Holdings After Transaction: Common Stock — 9,318 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 2,307 shares Reference price: $1.04 per share Shares held after: 9,318 shares

3 metrics

Shares granted 2,307 shares Grant, award, or other acquisition of common stock

Reference price $1.04 per share Value used for the 2,307-share grant

Shares held after 9,318 shares Direct common stock holdings following the transaction

Key Terms

Grant, award, or other acquisition, Common Stock, direct ownership

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

direct ownership financial

"ownership_type: direct"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 08:41 AM Accepted by SEC EDGAR 07/01/2026 - 08:40 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TALOR EYAL

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		2,307	A	$1.04	9,318	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Eyal Talor	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL SCI CORP (CVM) report for Talor Eyal?

CEL SCI CORP reported that Chief Scientific Officer Talor Eyal received a grant of 2,307 shares of common stock. This was recorded as a grant, award, or other acquisition rather than an open-market purchase or sale, reflecting equity-based compensation.

How many CEL SCI CORP (CVM) shares does Talor Eyal hold after the Form 4 transaction?

After the reported transaction, Chief Scientific Officer Talor Eyal directly holds 9,318 shares of CEL SCI CORP common stock. This total includes the new grant of 2,307 shares reported in the Form 4 insider filing as a compensation-related acquisition.

Was the CEL SCI CORP (CVM) Form 4 transaction a buy or a grant?

The transaction was a grant or award of shares, not an open-market buy. The Form 4 uses transaction code "A" and describes it as a grant, award, or other acquisition, indicating compensation rather than a discretionary market purchase by the insider.

What price per share is disclosed for Talor Eyal’s CEL SCI CORP (CVM) stock grant?

The filing shows a reference price of $1.04 per share for the 2,307 granted shares. This price is reported for Form 4 purposes and reflects the value used to describe the grant, not necessarily a cash purchase on the open market.

Does the CEL SCI CORP (CVM) Form 4 show any stock sales by Talor Eyal?

The Form 4 does not report any stock sales by Talor Eyal. It shows a single acquisition coded as a grant, award, or other acquisition, with 2,307 shares added to his direct holdings, bringing his total position to 9,318 common shares.